Categories AlphaGraphs, Earnings, Health Care
AMGN Earnings: Everything you need to know about Amgen’s Q2 results
Amgen Inc. (NASDAQ: AMGN) on Friday reported higher revenues and adjusted earnings for the second quarter of 2023. The biotechnology firm also provided guidance for fiscal 2023.
Adjusted earnings increased to $5.0 per share in the June quarter from $4.65 per share in the year-ago period. The reported net income was $1.38 billion or $2.57 per share in the latest quarter, compared to $1.32 billion or $2.45 per share in the same period of last year.
Total revenues increased 6% from last year to $6.98 billion during the three-month period. There was a 6% growth in product sales, benefiting from strong volume growth that was partially offset by 2% lower net selling price.
Prior Performance
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
